AMAmna Abdelgadir Mohamed

Amna Abdelgadir Mohamed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amna Abdelgadir Mohamed has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Early Neonatal Hyperglycemia, Risk Factors, and Adverse Outcomes in Extremely Preterm Infants: A Propensity-Matched Cohort Study

    by Safaa M. G. A. Alsayigh, Nuha Nimeri, Alaa Almashhadani, Amna Abdelgadir Mohamed, Omar Haidar, Muhammed Talha Hepsen, Ashraf Gad

    Background: Neonatal hyperglycemia is a common metabolic complication in extremely preterm (EP) infants; however, early risk factors and associated outcomes remain incompletely defined. Objective: To evaluate the association between neonatal hyperglycemia in the first postnatal week and key neonatal morbidities including early neurodevelopmental risk in EP infants. Methods: We conducted a retrospective cohort study of EP infants born in 2018–2019 at the Women’s Wellness and Research Center. Neonatal hyperglycemia was defined as a blood glucose level > 8.3 mmol/L. Maternal factors, delivery room interventions, early physiological markers, neonatal morbidities, and follow-up outcomes were compared. Propensity score matching was applied to balance the baseline demographic and perinatal differences. Results: Among 225 EP infants, 131 (58.2%) developed neonatal hyperglycemia in the first week (mild, 21.4%; moderate, 42%; severe, 36.6%). Before matching, infants with neonatal hyperglycemia had lower gestational age and birth weight and required more delivery-room surfactant, and their mothers had lower rates of premature rupture of membranes. After matching, neonatal hyperglycemia was associated with higher rates of ventilator-associated pneumonia (1.45 vs. 0.37; IRR 6.2, 95% CI 1.4–27.6), longer duration of invasive ventilation (19.8 ± 25.3 vs. 8.9 ± 24.8 days; mean difference −10.9 days; p = 0.042), higher postnatal steroid exposure (18.2% vs. 5.5%; OR 4.6, 95% CI 1.6–14.4; p = 0.040), and severe retinopathy of prematurity (ROP) (21.6% vs. 6.4%; OR 4.0, 95% CI 1.0–15.5; p = 0.032). A trend toward moderate-to-severe bronchopulmonary dysplasia was observed (33.3% vs. 15.9%; p = 0.054). Mortality did not differ significantly between groups; however, among non-survivors, age at death was higher in the neonatal hyperglycemia group. Conclusions: In EP infants, early neonatal hyperglycemia is associated with higher respiratory morbidity and severe ROP even after propensity score matching. These findings support neonatal hyperglycemia as a clinically relevant early risk marker and justify further prospective and interventional studies.


  • Open Access

    Early Neonatal Hyperglycemia, Risk Factors, and Adverse Outcomes in Extremely Preterm Infants: A Propensity-Matched Cohort Study

    by Safaa Alsayigh, Nuha Nimeri, Alaa Almashhadani, Amna Abdelgadir, Omar Haidar, Muhammed Talha, Ashraf Gad

    Background: Neonatal hyperglycemia (NH) is a common metabolic complication among (NH) infants. However, early risk factors and clinical outcomes of NH remain unclear. Objective: To evaluate the association of NH with clinical outcomes and neurodevelopmental(NDD) risk in EP infants. Methods: This retrospective propensity score matching (PSM) study, included EP, born between 2018-2019 at women’s wellness and research Center who met the NH criteria (blood glucose >8.3 mmol/L). Hyperglycemia severity, maternal factors, delivery room interventions, early physiological markers, neonatal morbidities, and follow-up outcomes were compared. Propensity score matching (1:1) was used to adjust for significant baseline demographics and clinical characteristics. Results: Out of 225 EP infants, 131 (58.2%) developed NH in the first week of life of infants, with mild hyperglycemia in 31.0%, moderate in 14.6%, and severe in 11.1% of cases. Before matching, infants with NH were more preterm and had lower birth weight and head circumference. Their mothers had lower rates of premature rupture of membranes (PPROM). Affected infants required more surfactant in the delivery room and had higher oxygen and mechanical ventilation needs during the first week. After matching, NH was associated with significantly higher rates of ventilator-associated pneumonia (VAP), with 23.6% vs 3.7%, OR 8.04 CI: 1.72–37.66, p=0.003, longer duration of mechanical ventilation (19.8±25.3 vs 8.9±24.8 days, MD -10.942, CI -21.470–-0.420, p=0.042), higher postnatal steroid use (18.2% vs 5.5%, OR 4.64, CI 1.56–14.37, p=0.040) After matching, NH was associated with significantly higher rates of severe retinopathy of prematurity (ROP), ( 21.6% vs 6.4%, OR 4.03 CI: 1.04–15.50, p= 0.032).and trend towards moderate to severe bronchopulmonary dysplasia (BPD) (33.3% vs 15.9%, OR 2.64, CI 0.96–7.23, p=0.054). No significant differences in mortality were observed between the groups; however, infants with NH who died were older. Conclusion: Early NH in EP infants is associated with an increased risk of ventilator-associated pneumonia, prolonged mechanical ventilation, severe ROP, and moderate to severe BPD. These findings suggest that NH may contribute to poorer short-term outcomes in this vulnerable population.